Phase III Clinical Study of Azvudine in Hiv-infected Treatment Naive Patients

NCT04303598 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

720

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV-infection/Aids

Interventions

DRUG: FNC
DRUG: 3TC
DRUG: TDF
DRUG: EFV
DRUG: FNC placebo
DRUG: 3TC placebo

Sponsor

Henan Genuine Biotech Co., Ltd.